Open AccessSuppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial
Author(s) -
Fariborz Mansour-Ghanaei,
Farahnaz Joukar,
Zahra Taherzadeh,
Homayoon Sokhanvar,
Tolou Hasandokht
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i21.5114
Subject(s) - medicine , endoscopic retrograde cholangiopancreatography , hyperamylasemia , pancreatitis , gastroenterology , abdominal pain , incidence (geometry) , naproxen , placebo , pancreatic duct , randomized controlled trial , abdomen , surgery , amylase , biochemistry , chemistry , physics , alternative medicine , pathology , optics , enzyme
To determine the efficacy of rectally administered naproxen for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP).